Ta-Cheng Chen

Learn More
PURPOSE The impact of epilepsy following different subtypes of stroke is unclear. The aim of this study was to evaluate the risk of post-stroke epilepsy with different stroke subtypes. METHODS A total of 4126 stroke patients and 24,756 age- and sex-matched controls were retrieved from the Longitudinal Health Insurance Database 2005, a major dataset of the(More)
The aim of this prospective, multicenter, open-label study was to investigate the efficacy of levetiracetam (LEV) and determine its effects on cognitive and neuropsychological function. Sixty-nine patients were evaluated for effects of LEV on seizure control, cognitive (Mini-Mental State Examination [MMSE]) and neuropsychological (Symptom Checklist-90(More)
Facing the phenomenon of "ageing population", the diagnosis and treatment of prostate cancer has become a serious men’s health issue in Taiwan. This study aimed to provide new scientific and quantitative information for traditional Chinese medicine (TCM) physicians in clinical practice of prostate cancer. In this study, data mining techniques were(More)
Thyroid hormone has been studied in cardiovascular disease but rarely in cerebrovascular disease (CVD). Recently, hypothyroidism has been suggested to be related to risk factors such as atherosclerosis but not directly to CVD. We reported a 52-year-old woman with acute ischemic stroke, and greatly improved general conditions after thyroid hormone(More)
BACKGROUND The dipeptidyl peptidase-4 (DPP-4) inhibitors sitagliptin, saxagliptin, and linagliptin are approved by the US Food and Drug Administration in the treatment of type-2 diabetes. Given the limited published information regarding human overdoses to these medications, our goal was to characterize such exposures. METHODS A state poison system(More)
Lung cancer disease is one of the dreaded disease is leading cause of death among men in developed and developing countries. Its cure rate and prognosis depends mainly on the early detection and diagnosis of the disease. Creating awareness among the general public about the disease and screening probable impact group requires lot of painstaking effort. This(More)
Zonisamide is an orally administered antiepileptic drug that was first approved for clinical use in Japan in 1989. Since then, it has been licensed in Korea for a broad spectrum of epilepsies in adults and children, and in the USA for adjunctive therapy of adults with partial seizures, and in Europe for monotherapy of adults with newly diagnosed partial(More)
  • 1